Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Peng M

From Bioblast
(Redirected from Peng Min)
Name Peng Min,
Institution Center for Mitochondrial and Epigenomic Medicine (CMEM)

The Children's Hospital of Philadelphia - Research Institute

Colket Translational Research Building

Address 3501 Civic Center Blvd, 19104
City Philadelphia
State/Province Pennsylvania (PA)
Country USA
Email [email protected]
Weblink
O2k-Network Lab US PA Philadelphia Wallace DC


Labels: Field of research: Basic 



Publications

 PublishedReference
Peng 2022 Front Oncol2022Peng M, Huang Y, Zhang L, Zhao X, Hou Y (2022) Targeting mitochondrial oxidative phosphorylation eradicates acute myeloid leukemic stem cells. Front Oncol 12:899502. https://doi.org/10.3389/fonc.2022.899502
Zhang 2013 PLoS One2013Zhang Z, Tsukikawa M, Peng M, Polyak E, Nakamaru-Ogiso E, Ostrovsky J, McCormack S, Place E, Clarke C, Reiner G, McCormick E, Rappaport E, Haas R, Baur JA, Falk MJ (2013) Primary respiratory chain disease causes tissue-specific dysregulation of the global transcriptome and nutrient-sensing signaling network. PLoS One 8:e69282.
Ziegler 2012 Mitochondrion2012Ziegler CG, Peng M, Falk MJ, Polyak E, Tsika E, Ischiropoulos H, Bakalar D, Blendy JA, Gasser DL (2012) Parkinson's disease-like neuromuscular defects occur in prenyl diphosphate synthase subunit 2 (Pdss2) mutant mice. Mitochondrion 12:248-57.
Falk 2012 EMBO Mol Med2012Falk MJ, Polyak E, Zhang Z, Peng M, King R, Maltzman JS, Okwuego E, Horyn O, Nakamaru-Ogiso E, Ostrovsky J, Xie LX, Chen JY, Marbois B, Nissim I, Clarke CF, Gasser DL (2012) Probucol ameliorates renal and metabolic sequelae of primary CoQ deficiency in Pdss2 mutant mice. EMBO Mol Med 3:410-27.

Abstracts

Add abstract

Participated at